A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors

被引：0
|
作者：
William Schelman
Sherry Morgan-Meadows
Howard Bailey
Kyle Holen
James P. Thomas
Jens Eickhoff
Heidi Brandon
Kate Oliver
Dona Alberti
George Wilding
机构：
[1] University of Wisconsin Paul P. Carbone Comprehensive Cancer Center,
[2] Southern Cancer Center,undefined
[3] The Ohio State University Comprehensive Cancer Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 62卷
关键词：
Gemcitabine; Patupilone; Chemotherapy; Phase I;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：727 / 733
页数：6
相关论文
共 50 条
  • [41] Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors
    Aspeslagh, Sandrine
    Shailubhai, Kunwar
    Bahleda, Rastilav
    Gazzah, Anas
    Varga, Andrea
    Hollebecque, Antoine
    Massard, Christophe
    Spreafico, Anna
    Reni, Michele
    Soria, Jean-Charles
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1257 - 1265
  • [42] Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors
    Stathis, A.
    Hess, D.
    von Moos, R.
    Homicsko, K.
    Griguolo, G.
    Joerger, M.
    Mark, M.
    Ackermann, C. J.
    Allegrini, S.
    Catapano, C. V.
    Xyrafas, A.
    Enoiu, M.
    Berardi, S.
    Gargiulo, P.
    Sessa, C.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (06) : 766 - 772
  • [43] Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors
    A. Stathis
    D. Hess
    R. von Moos
    K. Homicsko
    G. Griguolo
    M. Joerger
    M. Mark
    C. J. Ackermann
    S. Allegrini
    C. V. Catapano
    A. Xyrafas
    M. Enoiu
    S. Berardi
    P. Gargiulo
    C. Sessa
    Investigational New Drugs, 2017, 35 : 766 - 772
  • [44] Phase I trial of pomalidomide given for patients with advanced solid tumors
    Cooney, Matthew M.
    Nock, Charles
    Bokar, Joseph
    Krishnamurthi, Smitha
    Gibbons, Joseph
    Rodal, Mary Beth
    Ness, Anne
    Remick, Scot C.
    Dreicer, Robert
    Dowlati, Afshin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (05) : 755 - 761
  • [45] Phase I trial of pomalidomide given for patients with advanced solid tumors
    Matthew M. Cooney
    Charles Nock
    Joseph Bokar
    Smitha Krishnamurthi
    Joseph Gibbons
    Mary Beth Rodal
    Anne Ness
    Scot C. Remick
    Robert Dreicer
    Afshin Dowlati
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 755 - 761
  • [46] Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer
    van der Noll, R.
    Smit, W. M.
    Wymenga, A. N. M.
    Boss, D. S.
    Grob, M.
    Huitema, A. D. R.
    Rosing, H.
    Tibben, M. M.
    Keessen, M.
    Rehorst, H.
    Beijnen, J. H.
    Schellens, J. H. M.
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (06) : 1197 - 1205
  • [47] Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer
    R. van der Noll
    W. M. Smit
    A. N. M. Wymenga
    D. S. Boss
    M. Grob
    A. D. R. Huitema
    H. Rosing
    M. M. Tibben
    M. Keessen
    H. Rehorst
    J. H. Beijnen
    J. H. M. Schellens
    Investigational New Drugs, 2015, 33 : 1197 - 1205
  • [48] A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors
    Ryan, DP
    Lynch, TJ
    Grossbard, ML
    Seiden, MV
    Fuchs, CS
    Grenon, N
    Baccala, P
    Berg, D
    Finkelstein, D
    Mayer, RJ
    Clark, JW
    CANCER, 2000, 88 (01) : 180 - 185
  • [49] A phase I study of gemcitabine combined with vinblastine in patients with solid tumors
    Capuchino, I
    Suarez, ER
    del Giglio, A
    TUMORI, 2003, 89 (04) : 397 - 399
  • [50] Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors
    Rothenberg, ML
    Sharma, A
    Weiss, GR
    Villalona-Calero, MA
    Eckardt, JR
    Aylesworth, C
    Kraynak, MA
    Rinaldi, DA
    Rodriguez, GI
    Burris, HA
    Eckhardt, SG
    Stephens, CD
    Forral, K
    Nicol, SJ
    Von Hoff', DD
    ANNALS OF ONCOLOGY, 1998, 9 (07) : 733 - 738
12345